LDX
Lumos Diagnostics develops, manufactures and distributes rapid point-of-care diagnostic technologies. The company focuses on cost-effective tests and digital reader platforms, including products like FebriDx and ViraDx, to deliver actionable clinical information in real time at the point of care. It offers customized assay development, manufacturing transfer, validation, and regulatory support for diagnostic products. Based in Australia, Lumos operates with global reach and aims to advance point-of-care testing through integrated solutions.
No recent news for this company.
No recent deals for this company.